Komori
Osaka Soda (4046) · InitiativeFirst stated

Entering the Polymer Gel Market for Nucleic Acid and Peptide Medicines

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Entering the Polymer Gel Market for Nucleic Acid and Peptide MedicinesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「核酸・ペプチド医薬などの成長領域において新たな事業基盤を構築すべくポリマーゲル市場への参入を目指します。」

    ヘルスケア領域の新たな事業基盤として、核酸・ペプチド医薬などの成長領域に関連するポリマーゲル市場への参入を初めて明示している。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Osaka Soda yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.